| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850060 | American Heart Journal | 2006 | 8 Pages |
Abstract
Pioglitazone significantly increased the number and improved the functional properties of EPCs in type II diabetic patients through direct effects and/or anti-inflammation and lipid modification effects.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chao-Hung MD, Ming-Kuo MD, Subodh MD, PhD, FACC, Li-Tang MD, Ning-I MD, I-Chang MD, Shin-Yi BSc, Agnes BSc, Wen-Jin MD, FACC,